Most patent holders would agree that licensing patents for revenue has gone from bad to awful — from difficult less than a decade ago, to
Most patent holders would agree that licensing patents for revenue has gone from bad to awful — from difficult less than a decade ago, to
A California jury has awarded pharmaceutical drug company Merck $200 million, a fraction of what it had sought, for infringement of two of its patents
While many high-tech patents are suffering from devaluation the value of some pharmaceutical patents is soaring. Merck & Co. won a legal victory over
In an information age that worships data and transparency, the trade or business secret has never been more valuable. “Secrets” is an essential guide to
Companies that own intellectual property rights typically generate 29% higher revenue per employee, have about six times as many employees, and pay wages that are
Five recent articles challenge anti-IP myths driven by tech cos. Does the business media have the courage to follow? For decades patent enforcement has been
“When Patents Attack… Part II!” revisits old ground about bad IP actors by relying on half-truths and high drama. “This American Life,” an entertaining weekly
Am I seeing things or is the innovation capitol becoming less hospitable to really new ideas and strong patents? Are Silicon Valley’s guiding lights still
Big Blue may be caught in its image as the perennial patents-received leader, for better or worse. Obtaining large numbers of patents is often more
Attitude Toward Content Theft Fuels Free-Riding on Others’ Inventions & Counterfeits of Branded Products The ease of downloading copyrighted content on a computer or smart
Google, Facebook & Others are Suddenly IP Players Buying late and paying a premium for the patents that a company needs is no longer just a viable
iPlaces: Patents Pave Philadelphia Freeway Often overshadowed in technology and finance by the likes of San Francisco-Silicon Valley, Boston and New York, Philadelphia is right